Stephen Hilbert

Mr. Hilbert is the Chief Business Officer for OnocoSenX. He has served as business advisor since its inception and has served on several biotechnology company advisory boards specializing in business strategy and capital formation. Prior to OncoSenX in the Biotech space, Mr. Hilbert has served as corporate advisor to Immusoft and Kineta where he most recently served as VP of Corporate Development. His career spans over 10 years in biotech advisory and 18 years in the banking where he served as Vice President creating investment strategies and structures for accredited investors around the globe at JP Morgan and Charles Schwab.